C CHENG HLDGS (01486.HK): Sues Executive Director Deng Liming

On 20 November 2026, C CHENG HLDGS (01486.HK) sued executive director Deng Liming in Hong Kong's High Court for breach of duty over a parallel project.

NewTimeSpace News: On 20 November 2026, C Cheng Holdings Limited (stock code: 01486.HK) announced that the Company, as plaintiff, commenced legal proceedings at the Court of First Instance of the High Court of the Hong Kong Special Administrative Region that day under High Court Action No. 1994 of 2026 against Mr. Deng Liming, an executive Director.

Mr. Deng was appointed an executive Director on 12 September 2023 pursuant to a service agreement of the same date, and was entrusted with the day-to-day management and execution of a project concerning the development, production and commercialisation of radioisotopes used in medical diagnosis and treatment (the Panmediso Project). The Company alleges that, between about March and April 2025 and without its knowledge or consent, Mr. Deng established and/or became involved in a parallel project carrying on, or intended to carry on, the same or substantially similar business as the Panmediso Project, and that the parallel project was set up and/or developed through business connections, confidential information, investment opportunities and project resources he obtained as an executive Director and as the Company's representative on the Panmediso Project.

The Company further alleges that Mr. Deng failed to disclose his involvement in and interests in the parallel project, or to seek its prior consent, and that the Company only became aware of the project's existence and scale in or around April 2026. It is claiming an accounting of profits, damages and injunctive relief, and has obtained advice on the potential criminal liability of Mr. Deng and others and instructed legal representatives to file complaints with the relevant regulatory and criminal law enforcement bodies. The Company said the proceedings do not currently affect the Group's normal business and operations and will not have any material adverse impact on its business, operations or financial performance.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.